Session Information
2006 Midyear Clinical Meeting
Click here to go to the previous page
Current Clinical Practice: Comparing Guidelines in
Psychiatry with Evolving Evidence
Track:
Sessions
Program Code: 223-L01
Date: Tuesday, December 5, 2006
Time: 8:00 AM to 11:00 AM
Location:
304C-D (CC)
MODERATOR:
Karla M. Miller, Pharm.D., BCPP, Clinical Pharmacist, Psychiatry, Centennial Medical Center, Nashville, TN
SPEAKER(S):
Lawrence J. Cohen, Pharm.D., BCPP, FASHP, Professor of Pharmacotherapy, Washington State University College of Pharmacy; and Assistant Director for Psychopharmacology, Research and Training, WIMIRT, Spokane
Impact of Schizophrenia Guidelines on Formulary Management
Michael W. Jann, Pharm.D., BCPP, Chair, Department of Clinical and Administrative Sciences, Mercer University College of Pharmacy and Health Sciences, Atlanta, GA
Issues Surrounding Guidelines in the Treatment of Neuropsychiatric Symptoms in Dementia
Nicholas A. Votolato, B.S.Pharm., BCPP, Clinical Professor, Department of Pharmacy and Psychiatry, The Ohio State University, Columbus
Treating Mood Disorders in Medically Ill Patients
Description
Learning Objectives: Describe obstacles with current guidelines in psychiatry. Compare and contrast the atypical versus conventional antipsychotics in the treatment of schizophrenia. List therapeutic options for the treatment of neuropsychiatry symptoms associated with dementia. Describe the challenges in treating mood disorders in medically ill patients.